These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9131778)

  • 1. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.
    Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
    Synapse; 1997 Jun; 26(2):194-8. PubMed ID: 9131778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
    Pickel VM; Chan J; Nirenberg MJ
    Synapse; 2002 Aug; 45(2):113-24. PubMed ID: 12112404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.
    Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
    J Neurosci; 1996 Jul; 16(13):4135-45. PubMed ID: 8753875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
    Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
    Yao J; Erickson JD; Hersh LB
    Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
    J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1150-3. PubMed ID: 11504813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient developmental expression of monoamine transporters in the rodent forebrain.
    Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
    J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
    Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for histamine as a transmitter in rat carotid body sensor cells.
    Koerner P; Hesslinger C; Schaefermeyer A; Prinz C; Gratzl M
    J Neurochem; 2004 Oct; 91(2):493-500. PubMed ID: 15447682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter.
    Verney C; Lebrand C; Gaspar P
    Anat Rec; 2002 Jun; 267(2):87-93. PubMed ID: 11997877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.
    Weihe E; Tao-Cheng JH; Schäfer MK; Erickson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3547-52. PubMed ID: 8622973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.
    Truong JG; Newman AH; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2004 Nov; 504(1-2):27-32. PubMed ID: 15507217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.